Search

everythinglearnresearchcommunity

for

Search:↓

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

Using a niacinamide cream can improve life quality for breast cancer patients during chemotherapy.

Combining cytostatic and steroid drugs effectively treats systemic lupus erythematosus.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

The paper concludes that the patchiness of alopecia areata is likely due to when the immune attack happens in the hair growth cycle.

A child on life support experienced rapid hair loss due to severe illness affecting hair growth.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

People with lichen planopilaris often have seborrheic dermatitis, which can delay the diagnosis of lichen planopilaris.

Online medical education helps doctors make better clinical decisions and increases their knowledge in treating fungal nail infections.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

Microneedling with bleomycin effectively treats plantar warts with fewer sessions.

Nitric oxide gel helps heal skin burns faster by improving skin growth, hair regrowth, and blood vessel formation.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Some drugs can cause hair loss or increase hair growth, but these effects are usually reversible when the drug is stopped.

No treatment fully prevents hair loss from chemotherapy yet.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Most hair loss in children is caused by a few common conditions, and it's important to diagnose these properly and support the child's mental health.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.